Article
Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro.
Journal of chemical information and modeling - 26 Oct 2020
Sheik Amamuddy Olivier, Verkhivker Gennady M, Tastan Bishop Özlem
Abstract excerpt
A new coronavirus (SARS-CoV-2) is a global threat to world health and economy. Its dimeric main protease (Mpro), which is required for the proteolytic cleavage of viral precursor proteins, is a good candidate for drug development owing to its conservation and the absence of a human homolog. Improving our understanding of Mpro behavior can accelerate the discovery of effective therapies to reduce mortality....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
